The NCCN Oncology Research Program (ORP) Received a $2-Million Grant From Boehringer Ingelheim Pharmaceuticals, Inc. to Facilitate Studies of Afatinib in Non-Small Cell Lung Cancer FORT WASHINGTON, PA–(Marketwired – June […]
Featured Posts
Establishing Procedures Helps Address Regulatory-Based Inquiries, According to Cutting Edge Information RESEARCH TRIANGLE PARK, NC–(Marketwired – June 10, 2015) – Even without pricing considerations, securing reimbursement status starts with being […]
That’s a pretty provocative headline coming from an Avalere report sponsored by America’s Health Insurance Plans (AHIP), the national trade association that represents the health insurance industry. At a time […]
A tepid recommendation from an expert advisory panel could limit the sales of new cholesterol drugs, but they could still become $1 billion products in the near term, and generate […]
Januvia, a widely used diabetes drug that generates $6 billion in annual sales for maker Merck, does not increase patients’ risk of being hospitalized for heart failure, a risk that […]
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Inc. (OTCBB: INSV) today announced that it has reached a definitive agreement with QLT Inc. (NASDAQ: QLTI) (TSX: QLT) under which QLT will acquire InSite in […]
Merck has done some dramatic things in antibiotics lately. Six months ago, it bought Lexington, Mass.-based Cubist Pharmaceuticals, a leader in the field, for $8.4 billion. Then it laid off […]
Ordinarily, I differ with Harvard Medical School’s Dr. Jerry Avorn on healthcare issues, particularly when it comes to his views on the pharmaceutical industry. For example, we are on opposite […]
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) announced today that it has twelve presentations, including new research data on tofacitinib for chronic plaque psoriasis and atopic dermatitis, at the upcoming 23rd World […]
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces results from a Phase 1b clinical trial with LGD-6972 that demonstrate favorable safety, tolerability and pharmacokinetics in normal healthy volunteers and in […]